The first grains of rock and dust from asteroid Bennu are turning out to be far richer than many scientists dared hope, ...

Mursla Bio Ltd. recently entered a partnership with an unnamed large pharmaceutical company to use its AI Precision Medicine ...

Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...

The OkaiDx Detect Pancreatic Cancer test has not been cleared or approved by the U.S. Food and Drug Administration, results are from an independently conducted EG BioMed study and remain under ...

Sunbird Bio, a biotechnology company developing proprietary blood-based technologies to improve diagnosis and treatment of ...

PRNewswire/ -- bit.bio, the global leader in cell programming technology, today announces the publication of its 2025 ...

YD Bio (YDES)provided an update to its November 5, 2025 announcement regarding U.S. access to the OkaiDx platform for post-treatment breast cancer ...

Lexogen, a Vienna-based biotech company specialized in RNA transcriptomics technologies and services announces the completion ...

Why our top picks of the year were about serial killers, silence and the enduring grace of the written word, according to The ...

Internal clocks can tick very differently. While some people are most productive in the morning, others are only active later ...

The Global Bio Preservation Market presents growth opportunities driven by the rising demand for organ transplants and ...

The Precision Fermentation Market is expanding rapidly as advancements in synthetic biology, growing consumer preference for sustainable and alternative proteins, and increasing investments in ...